4//SEC Filing
Hindson Benjamin J. 4
Accession 0001610717-23-000214
CIK 0001770787other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 5:31 PM ET
Size
12.0 KB
Accession
0001610717-23-000214
Insider Transaction Report
Form 4
Hindson Benjamin J.
DirectorSee Remarks
Transactions
- Exercise/Conversion
Class A Common Stock
2023-07-19$11.48/sh+968$11,113→ 298,176 total - Sale
Class A Common Stock
2023-07-19$60.03/sh−13,940$836,834→ 284,236 total - Exercise/Conversion
Class A Common Stock
2023-07-19$5.04/sh+12,972$65,379→ 297,208 total - Exercise/Conversion
Stock Option (right to buy)
2023-07-19−12,972→ 0 totalExercise: $5.04Exp: 2028-11-02→ Class A Common Stock (12,972 underlying) - Exercise/Conversion
Stock Option (right to buy)
2023-07-19−968→ 30,282 totalExercise: $11.48Exp: 2029-05-10→ Class A Common Stock (968 underlying)
Footnotes (3)
- [F1]The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $60.00 to $60.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]All of the shares subject to the option are fully vested and exercisable as of the date hereof.
Documents
Issuer
10x Genomics, Inc.
CIK 0001770787
Entity typeother
Related Parties
1- filerCIK 0001786391
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 5:31 PM ET
- Size
- 12.0 KB